These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34093004)

  • 1. Neurological manifestations and neuroimaging findings in patients with SARS-CoV2-a systematic review.
    Mohan N; Fayyaz MA; Del Rio C; Khurana NKRS; Vaidya SS; Salazar E; Joyce J; Ali AA
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):68. PubMed ID: 34093004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Neurological Manifestations of SARS-CoV-2.
    Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
    Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
    Sriwastava S; Tandon M; Podury S; Prasad A; Wen S; Guthrie G; Kakara M; Jaiswal S; Subedi R; Elkhooly M; Lisak RP
    J Neurol; 2021 Dec; 268(12):4448-4478. PubMed ID: 34009454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
    Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
    World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
    Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
    Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of neurological symptoms and complications of COVID-19.
    Chen X; Laurent S; Onur OA; Kleineberg NN; Fink GR; Schweitzer F; Warnke C
    J Neurol; 2021 Feb; 268(2):392-402. PubMed ID: 32691236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review.
    Correia AO; Feitosa PWG; Moreira JLS; Nogueira SÁR; Fonseca RB; Nobre MEP
    Neurol Psychiatry Brain Res; 2020 Sep; 37():27-32. PubMed ID: 32834527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of coronavirus infections - a systematic review.
    Almqvist J; Granberg T; Tzortzakakis A; Klironomos S; Kollia E; Öhberg C; Martin R; Piehl F; Ouellette R; Ineichen BV
    Ann Clin Transl Neurol; 2020 Oct; 7(10):2057-2071. PubMed ID: 32853453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of CSF, Serum and Neuroimaging Markers in CNS and PNS Manifestation in COVID-19: A Systematic Review of Case Report and Case Series.
    Podury S; Srivastava S; Khan E; Kakara M; Tandon M; Shrestha AK; Freeland K; Wen S; Sriwastava S
    Brain Sci; 2021 Oct; 11(10):. PubMed ID: 34679418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: dealing with a potential risk factor for chronic neurological disorders.
    Schirinzi T; Landi D; Liguori C
    J Neurol; 2021 Apr; 268(4):1171-1178. PubMed ID: 32852580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.